« Back
Home /
(+)-JQ-1

(+)-JQ-1

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	500 mg
Item no.	HY-13030-500mg
Targets	Epigenetic Reader Domain; Autophagy; Ligands for Target Protein for PROTAC
CASRN	1268524-70-4
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	(+)-JQ-1 (JQ1) is a potent, specific, and reversible BET bromodomain inhibitor, with IC50s of 77 and 33 nM for the first and second bromodomain (BRD4(1/2))[1]. (+)-JQ-1 also activates autophagy[2].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	456.99
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer
Solubility	DMSO : ≥ 45 mg/mL
Manufacturers Target	Autophagy; Epigenetic Reader Domain; Ligands for Target Protein for PROTAC
Pathway	Autophagy; Epigenetics; PROTAC
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-13030-500mg-safety-datasheet.pdf